Summary
Boston Scientific Corporation (BSX) filed an 8-K on February 7, 2006, to report its financial results for the year and fourth quarter ended December 31, 2005. This filing primarily serves as a notification of the release of this information, with the detailed financial results contained within an accompanying press release furnished as an exhibit. While the 8-K itself does not contain the specific financial figures, it indicates that investors should refer to the press release for details on the company's operational performance and financial condition. This is a standard procedure for reporting significant financial updates and provides investors with timely access to the company's latest performance metrics.
Key Highlights
- 1The 8-K filing on February 7, 2006, announces Boston Scientific's financial results for the year and fourth quarter of 2005.
- 2The report's primary purpose is to furnish a press release detailing these financial results.
- 3The press release, attached as Exhibit 99.1, contains the specific operational and financial performance data.
- 4This filing is a notification mechanism to make investors aware of the updated financial information.
- 5The information provided is not considered 'filed' for certain SEC liability purposes, emphasizing the reference to the press release for substance.